| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PNAS..110.3270B |
| P356 | DOI | 10.1073/PNAS.1216893110 |
| P932 | PMC publication ID | 3587278 |
| P698 | PubMed publication ID | 23401509 |
| P5875 | ResearchGate publication ID | 235524200 |
| P50 | author | Samir Mitragotri | Q7409527 |
| Poornima Kolhar | Q125197006 | ||
| P2093 | author name string | Sutapa Barua | |
| Jin-Wook Yoo | |||
| Yatin R Gokarn | |||
| Aditya Wakankar | |||
| P2860 | cites work | Understanding biophysicochemical interactions at the nano-bio interface | Q23909863 |
| Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions | Q24793110 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| In vivo cancer targeting and imaging with semiconductor quantum dots | Q29617278 | ||
| Role of target geometry in phagocytosis | Q30477258 | ||
| Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. | Q30492713 | ||
| Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer | Q33303505 | ||
| Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy | Q33393360 | ||
| Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles | Q33666994 | ||
| Determining force dependence of two-dimensional receptor-ligand binding affinity by centrifugation | Q34167171 | ||
| Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies | Q35213038 | ||
| Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab | Q35234716 | ||
| Making polymeric micro- and nanoparticles of complex shapes | Q35901299 | ||
| HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization. | Q36559225 | ||
| Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer | Q36619966 | ||
| The effect of particle design on cellular internalization pathways | Q36954579 | ||
| Size-Dependent Endocytosis of Nanoparticles | Q37259900 | ||
| Nanoparticle-mediated IgE-receptor aggregation and signaling in RBL mast cells | Q37452213 | ||
| Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn. | Q37597698 | ||
| Multivalent antibodies: when design surpasses evolution. | Q37744013 | ||
| Anti-interleukin-5 antibody therapy in asthma and allergies | Q37942420 | ||
| The effect of nanoparticle size, shape, and surface chemistry on biological systems | Q38004588 | ||
| Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. | Q39312304 | ||
| Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization. | Q39343797 | ||
| Targeted luminescent near-infrared polymer-nanoprobes for in vivo imaging of tumor hypoxia | Q39456529 | ||
| The effects of serum on the toxicity of manufactured nanoparticles | Q39668217 | ||
| Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI. | Q39922892 | ||
| Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. | Q40099080 | ||
| Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice | Q40183903 | ||
| Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. | Q40271000 | ||
| Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention | Q40367017 | ||
| ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer | Q41270960 | ||
| Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots | Q42807706 | ||
| Nanoparticle-mediated cellular response is size-dependent. | Q47223945 | ||
| Structural basis of antibody-antigen interactions. | Q47983492 | ||
| Encapsulation of biomolecules for bioanalytical purposes: preparation of diclofenac antibody-doped nanometer-sized silica particles by reverse micelle and sol-gel processing. | Q50925859 | ||
| The adhesive strength of non-spherical particles mediated by specific interactions. | Q51174053 | ||
| Equilibrium binding of multivalent ligands to cells: effects of cell and receptor density. | Q52301341 | ||
| Functional groups on polystyrene model nanoparticles: Influence on protein adsorption | Q52951619 | ||
| Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery. | Q55518386 | ||
| Comparative studies on the interaction of proteins with a polydimethylsiloxane elastomer. I. Monolayer protein capture capacity (PCC) as a function of protein pl, buffer pH and buffer ionic strength | Q73406656 | ||
| Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody | Q80351088 | ||
| Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial | Q81658198 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| antibody | Q79460 | ||
| P304 | page(s) | 3270-3275 | |
| P577 | publication date | 2013-02-11 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Particle shape enhances specificity of antibody-displaying nanoparticles | |
| P478 | volume | 110 |
| Q46553931 | A New Spin on Antibody-Drug Conjugates: Trastuzumab-Fulvestrant Colloidal Drug Aggregates Target HER2-Positive Cells. |
| Q58356982 | A colloidally stable water dispersion of Ni nanowires as an efficient T2-MRI contrast agent |
| Q50208970 | A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy |
| Q42019484 | A pH-sensitive, biobased calcium carbonate aragonite nanocrystal as a novel anticancer delivery system |
| Q47312662 | Advanced manufacturing of microdisk vaccines for uniform control of material properties and immune cell function. |
| Q41495734 | An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles |
| Q33560058 | Anchored but not internalized: shape dependent endocytosis of nanodiamond |
| Q38665261 | Antibody-targeted biodegradable nanoparticles for cancer therapy |
| Q60307766 | Aspherical and Spherical InvA497-Functionalized Nanocarriers for Intracellular Delivery of Anti-Infective Agents |
| Q47904590 | Aspherical, Nanostructured Microparticles for Targeted Gene Delivery to Alveolar Macrophages |
| Q37227832 | Bifunctional Luminomagnetic Rare-Earth Nanorods for High-Contrast Bioimaging Nanoprobes |
| Q58343990 | Bio-inspired nanotadpoles with component-specific functionality |
| Q93184920 | Biocompatibility studies of fluorescent diamond particles-(NV)~800nm (part V): in vitro kinetics and in vivo localization in rat liver following long-term exposure |
| Q41495742 | Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation |
| Q57480337 | Biomaterials for vaccine-based cancer immunotherapy |
| Q96110486 | Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal |
| Q38567436 | Biomimetic particles as therapeutics |
| Q34447986 | Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. |
| Q54503961 | Carbon-coated nanoparticle superlattices for energy applications. |
| Q36396004 | Cell membrane-camouflaged nanoparticles for drug delivery |
| Q38603358 | Coating nanoparticles with cell membranes for targeted drug delivery |
| Q89506260 | Complex three-dimensional microparticles from microfluidic lithography |
| Q44436580 | Controlling and predicting crystal shapes: the case of urea. |
| Q36793350 | Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery |
| Q64929609 | Decorating Nanoparticle Surface for Targeted Drug Delivery: Opportunities and Challenges. |
| Q47795007 | Determination of Nonspherical Morphology of Doxorubicin-Loaded Liposomes by Atomic Force Microscopy |
| Q89909999 | Development of PLGA micro- and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery |
| Q42221725 | Discrete Element Method Simulations of the Inter-Particle Contact Parameters for the Mono-Sized Iron Ore Particles |
| Q97074955 | Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers |
| Q34019320 | EFFECTS OF POLYMERIC NANOPARTICLE SURFACE PROPERTIES ON INTERACTION WITH BRAIN TUMOR ENVIRONMENT. |
| Q48047593 | Effect of internal architecture on microgel deformation in microfluidic constrictions |
| Q37418559 | Effect of polyplex morphology on cellular uptake, intracellular trafficking, and transgene expression |
| Q47361903 | Effect of shape, size, and aspect ratio on nanoparticle penetration and distribution inside solid tissues using 3D spheroid models. |
| Q34731969 | Effects of PEGylation on the physicochemical properties and in vivo distribution of organic nanotubes |
| Q37650579 | Effects of the Microparticle Shape on Cellular Uptake |
| Q34144680 | Electrostatics-driven shape transitions in soft shells. |
| Q37258701 | Exploiting endocytosis for nanomedicines |
| Q36994905 | Flexible Octopus-Shaped Hydrogel Particles for Specific Cell Capture |
| Q90230183 | Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment |
| Q56902291 | Formation of Polymeric Nanocubes by Self-Assembly and Crystallization of Dithiolane-Containing Triblock Copolymers |
| Q47822397 | Formation of Polymeric Nanocubes by Self-Assembly and Crystallization of Dithiolane-Containing Triblock Copolymers. |
| Q57367782 | Glycopolymer-coated gold nanorods synthesised by a one pot copper(0) catalyzed tandem RAFT/click reaction |
| Q57368426 | Glycopolymer-coated iron oxide nanoparticles: shape-controlled synthesis and cellular uptake |
| Q86484124 | Gold nanorods mediated controlled release of doxorubicin: nano-needles for efficient drug delivery |
| Q58699763 | Growing gold nanostructures for shape-selective cellular uptake |
| Q41035496 | Heteromer Nanostars by Spontaneous Self-Assembly |
| Q92644551 | Improving nanotherapy delivery and action through image-guided systems pharmacology |
| Q39100997 | In vitro delivery and controlled release of Doxorubicin for targeting osteosarcoma bone cancer. |
| Q33854364 | In vitro ultrastructural changes of MCF-7 for metastasise bone cancer and induction of apoptosis via mitochondrial cytochrome C released by CaCO3/Dox nanocrystals |
| Q35000572 | Intelligent Nanoparticles for Advanced Drug Delivery in Cancer Treatment |
| Q92730799 | Internalization Characterization of Si Nanorod with Camouflaged Cell Membrane Proteins Reveals ATXN2 as a Negative Regulator |
| Q38112171 | Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition |
| Q28118688 | Lacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticles |
| Q27002652 | Linking form to function: Biophysical aspects of artificial antigen presenting cell design |
| Q38115981 | Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. |
| Q37231636 | Magneto-electric nanoparticles to enable field-controlled high-specificity drug delivery to eradicate ovarian cancer cells |
| Q37255871 | Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms |
| Q36084836 | Measuring protein isoelectric points by AFM-based force spectroscopy using trace amounts of sample |
| Q51239630 | Mechanism for the Cellular Uptake of Targeted Gold Nanorods of Defined Aspect Ratios. |
| Q59794602 | Membrane reorganization after photochemical internalization to release transferrin-biofunctionalized polystyrene microparticles |
| Q52397658 | Microfluidic co-culture devices to assess penetration of nanoparticles into cancer cell mass. |
| Q26827999 | Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency |
| Q38994774 | Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery |
| Q38878171 | Multivalent targeting of AT1 receptors with angiotensin II-functionalized nanoparticles. |
| Q91640738 | Nano-Ghosts: Biomimetic membranal vesicles, technology and characterization |
| Q27023634 | Nanoengineering approaches to the design of artificial antigen-presenting cells |
| Q42371683 | Nanoformulations of curcumin: an emerging paradigm for improved remedial application |
| Q49351130 | Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells |
| Q44874726 | Nanoparticle conversion chemistry: Kirkendall effect, galvanic exchange, and anion exchange. |
| Q38641001 | Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research |
| Q50226473 | Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics |
| Q33961538 | Nanopharmacology in translational hematology and oncology |
| Q52662884 | Nanoscale artificial antigen presenting cells for cancer immunotherapy. |
| Q36062053 | Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting |
| Q38261278 | Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications. |
| Q52314663 | Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant. |
| Q46053279 | One-step two-dimensional microfluidics-based synthesis of three-dimensional particles |
| Q47225568 | Optimization and comparison of CD4-targeting lipid-polymer hybrid nanoparticles using different binding ligands. |
| Q51116756 | Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release. |
| Q37515801 | Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells |
| Q28087396 | Particle tracking in drug and gene delivery research: State-of-the-art applications and methods |
| Q38564510 | Polymeric micro/nanoparticles: Particle design and potential vaccine delivery applications |
| Q38779343 | Polysilicon-chromium-gold intracellular chips for multi-functional biomedical applications |
| Q52590993 | Progress and challenges towards targeted delivery of cancer therapeutics. |
| Q36118071 | Recommendations for Benchmarking Preclinical Studies of Nanomedicines |
| Q53077423 | Research highlights: Highlights from the last year in nanomedicine. |
| Q41674798 | Role of nanoparticle size, shape and surface chemistry in oral drug delivery |
| Q38573793 | Role of particle size, shape, and stiffness in design of intravascular drug delivery systems: insights from computations, experiments, and nature |
| Q35801327 | Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery. |
| Q34727867 | Shape Transformation Following Reduction-Sensitive PEG Cleavage of Polymer/DNA Nanoparticles. |
| Q58570526 | Shape-based separation of micro-/nanoparticles in liquid phases |
| Q33755231 | Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles |
| Q36279715 | Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle design |
| Q49163557 | Simulation and Experimental Assembly of DNA-Graft Copolymer Micelles with Controlled Morphology. |
| Q95643273 | Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow |
| Q64113339 | Smart nanoplatform for sequential drug release and enhanced chemo-thermal effect of dual drug loaded gold nanorod vesicles for cancer therapy |
| Q40214162 | Surface engineering for lymphocyte programming |
| Q37502278 | Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells. |
| Q34028831 | Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles |
| Q35565769 | Synthetic tumor networks for screening drug delivery systems |
| Q39393477 | Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications |
| Q36579751 | Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles |
| Q38712188 | Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody |
| Q38703125 | Taxane-Grafted Metal-Oxide Nanoparticles as a New Theranostic Tool against Cancer: The Promising Example of Docetaxel-Functionalized Titanate Nanotubes on Prostate Tumors. |
| Q99565139 | The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs |
| Q33813541 | The More Exotic Shapes of Semiconductor Nanocrystals: Emerging Applications in Bioimaging |
| Q36879520 | The aspect ratio of nanoparticle assemblies and the spatial arrangement of ligands can be optimized to enhance the targeting of cancer cells |
| Q39605163 | The interaction of protein-coated bionanoparticles and surface receptors reevaluated: how important is the number of bonds? |
| Q58619853 | The right touch: design of artificial antigen-presenting cells to stimulate the immune system |
| Q51766271 | Tunable particles alter macrophage uptake based on combinatorial effects of physical properties. |
| Q61446921 | Ultrasmall gold nanorods: synthesis and glycocalyx-related permeability in human endothelial cells |
| Q36967705 | Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium |
| Q92533382 | Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics |
| Q36291687 | Virus-like nanostructures for tuning immune response. |
| Q38808367 | pH-Responsive Wormlike Micelles with Sequential Metastasis Targeting Inhibit Lung Metastasis of Breast Cancer |
Search more.